Neuronetics, Inc. (STIM) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neuronetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.094 Good day and thank you for standing by. Welcome to the Neuronetics 00:00:05.094 -- 00:00:10.237 Report Second Quarter 2026 Financial and Operating Results Conference Call. 00:00:10.237 -- 00:00:13.599 At this time, all participants are in the listen-only mode. 00:00:13.599 -- 00:00:17.461 After the speaker's presentation, there will be a question and answer session. 00:00:17.461 -- 00:00:21.984 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:21.984 -- 00:00:25.866 You will then hear an automated message advising that your hand is raised. 00:00:25.866 -- 00:00:29.268 Please be advised that today's conference is being recorded. 00:00:29.268 -- 00:00:33.071 I would now like to end the conference over to your first speaker today, Mike Valli from 00:00:33.071 -- 00:00:36.353 ICR Healthcare. Please go ahead. 00:00:36.353 -- 00:00:40.937 Good morning and thank you for joining us for the Neuronetics second quarter 2026 conference 00:00:40.937 -- 00:00:46.140 call. Joining me on today's call are the Neuronetics President and Chief Executive Officer 00:00:46.140 -- 00:00:51.860 Dan Revers and the company's recently appointed Chief Financial Officer Nir Nair. 00:00:51.860 -- 00:00:55.802 Before we begin, I would like to caution listeners that certain information discussed 00:00:55.802 -- 00:01:00.384 by management during this conference call will include forward-looking statements covered 00:01:00.384 -- 00:01:05.987 under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, 00:01:05.987 -- 00:01:11.449 including statements related to our business, strategy, financial and revenue guidance, 00:01:11.449 -- 00:01:15.010 and other operational issues and metrics. 00:01:...